IMATIRON 400 MG

IMATIRON 400 MG contains Imatinib Mesylate 400 mg, a targeted tyrosine kinase inhibitor (TKI) used to treat certain types of cancers such as Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).

Imatinib works by blocking abnormal proteins that signal cancer cells to grow. By stopping these signals, IMATIRON 400 MG helps control the growth and spread of cancer cells, improving survival rates and quality of life in affected patients.

✅ Key Benefits:

• First-line treatment for Chronic Myeloid Leukemia (CML)

• Effective against Philadelphia chromosome-positive (Ph+) leukemias

• Approved for use in Gastrointestinal Stromal Tumors (GIST)

• Well-studied targeted cancer therapy

• Improves remission rates and disease control